SUPPLEMENTARY MATERIAL: Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study
Published: 29 July 2025| Version 1 | DOI: 10.17632/krgr4mrh56.1
Contributors:
Todd Schlesinger, M. Shane Chapman, John H. Tu, Joel L. Cohen, John Strasswimmer, Nathalie C. Zeitouni, Abel Torres, S. Sasha Jazayeri, Mitchel P. Goldman, Sherrif F. Ibrahim, Edward L. Lain, Megan P. Couvillion, Suzanne Bruce, Vivian T. Laquer, C. William Hanke, David Ozog, Jane Schneider, Orit Markowitz, Brian Berman, Mark S. Nestor, Michael H. Gold, Girish S. Munavalli, Douglass W. Forsha, Daniel M. Siegel, David Mrohs, Beate Schmitz, Ruth Schäning, Nicole Pospiech, Jon Lyons, Montserrat Foguet, Matthias Lübbert, Hermann Lübbert, David M. PariserDescription
Supplementary material for the manuscript "Red light photodynamic therapy with 10% aminolevulinic acid gel showed efficacy for treatment of superficial basal cell carcinoma in a randomized, vehicle controlled, double-blind, multicenter phase III study"
Files
Categories
Basal Cell Carcinoma, Photodynamic Therapy, Aminolevulinic Acid, Randomized Clinical Trial
Funders
- Biofrontera Bioscience GmbH